> top > docs > PubMed:8809472 > annotations

PubMed:8809472 JSONTXT

Annnotations TAB JSON ListView MergeView

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 106-114 protein denotes cytokine
T2 200-223 cell_line denotes transformed lymphocytes
T3 941-961 protein denotes "normal" lymphokines
T4 965-974 protein denotes cytokines
T5 1059-1068 protein denotes cytokines
T6 1131-1154 cell_line denotes transformed lymphocytes
T7 1548-1556 protein denotes cytokine

genia-medco-coref

Id Subject Object Predicate Lexical cue
C3 0-10 NP denotes Mechanisms
C4 11-15 NP denotes that
C16 49-70 NP denotes lymphoid malignancies
C1 82-101 NP denotes genetic alterations
C2 155-174 NP denotes genetic alterations
C5 256-273 NP denotes these alterations
C10 296-314 NP denotes lymphoid neoplasms
C12 277-314 NP denotes the development of lymphoid neoplasms
C7 326-353 NP denotes the genes encoding proteins
C8 354-358 NP denotes that
C18 515-544 NP denotes certain lymphoid malignancies
C9 605-629 NP denotes such genetic alterations
C11 685-709 NP denotes these lymphoid neoplasms
C13 666-709 NP denotes the development of these lymphoid neoplasms
C14 786-794 NP denotes proteins
C15 795-799 NP denotes that
C17 870-891 NP denotes lymphoid malignancies
C19 941-974 NP denotes "normal" lymphokines of cytokines
C20 975-980 NP denotes which
C21 993-1026 NP denotes many lymphoproliferative diseases
C27 1028-1086 NP denotes The dysregulated expression of cytokines during malignancy
C22 1351-1379 NP denotes lymphoproliferative diseases
C23 1418-1428 NP denotes the notion
C24 1429-1433 NP denotes that
C25 1453-1474 NP denotes lymphoid malignancies
C26 1504-1523 NP denotes genetic alterations
C28 1535-1567 NP denotes dysregulated cytokine expression
R1 C4 C3 coref-relat that,Mechanisms
R2 C2 C1 coref-ident genetic alterations,genetic alterations
R3 C5 C2 coref-ident these alterations,genetic alterations
R4 C8 C7 coref-relat that,the genes encoding proteins
R5 C18 C16 coref-part-whole certain lymphoid malignancies,lymphoid malignancies
R6 C9 C5 coref-ident such genetic alterations,these alterations
R7 C11 C10 coref-ident these lymphoid neoplasms,lymphoid neoplasms
R8 C13 C12 coref-ident the development of these lymphoid neoplasms,the development of lymphoid neoplasms
R9 C15 C14 coref-relat that,proteins
R10 C17 C16 coref-ident lymphoid malignancies,lymphoid malignancies
R11 C20 C19 coref-relat which,"""normal"" lymphokines of cytokines"
R12 C22 C21 coref-whole-part lymphoproliferative diseases,many lymphoproliferative diseases
R13 C24 C23 coref-relat that,the notion
R14 C25 C17 coref-ident lymphoid malignancies,lymphoid malignancies
R15 C26 C1 coref-ident genetic alterations,genetic alterations
R16 C28 C27 coref-ident dysregulated cytokine expression,The dysregulated expression of cytokines during malignancy

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-126 Sentence denotes Mechanisms that contribute to the development of lymphoid malignancies: roles for genetic alterations and cytokine production.
S2 127-224 Sentence denotes Recent studies have defined genetic alterations commonly associated with transformed lymphocytes.
S3 225-315 Sentence denotes This review suggests roles for these alterations in the development of lymphoid neoplasms.
S4 316-545 Sentence denotes Damage to the genes encoding proteins that function in intracellular signaling, transcription, or regulation of the cell cycle has been identified and linked at varying degrees to the progression of certain lymphoid malignancies.
S5 546-710 Sentence denotes An understanding of the mechanistic consequences following such genetic alterations is essential to an understanding of the development of these lymphoid neoplasms.
S6 711-892 Sentence denotes In contrast, it is also becoming clear that the dysregulated expression of proteins that are not genetically altered can also contribute to the progression of lymphoid malignancies.
S7 893-1027 Sentence denotes One such example is the excessive expression of "normal" lymphokines of cytokines which accompanies many lymphoproliferative diseases.
S8 1028-1215 Sentence denotes The dysregulated expression of cytokines during malignancy can result in the augmentation of growth of transformed lymphocytes, as well as an alteration of the anti-tumor immune response.
S9 1216-1380 Sentence denotes The latter mechanism is especially important because evasion of the impending immune response is a prerequisite for the progression of lymphoproliferative diseases.
S10 1381-1568 Sentence denotes Taken together, this review supports the notion that the development of lymphoid malignancies is multifactorial, involving genetic alterations as well as dysregulated cytokine expression.

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 49-70 other_name denotes lymphoid malignancies
T2 106-114 protein_family_or_group denotes cytokine
T3 200-223 cell_line denotes transformed lymphocytes
T4 296-314 other_name denotes lymphoid neoplasms
T5 371-394 other_name denotes intracellular signaling
T6 432-442 other_name denotes cell cycle
T7 523-544 other_name denotes lymphoid malignancies
T8 610-629 other_name denotes genetic alterations
T9 691-709 other_name denotes lymphoid neoplasms
T10 870-891 other_name denotes lymphoid malignancies
T11 941-961 protein_family_or_group denotes "normal" lymphokines
T12 965-974 protein_family_or_group denotes cytokines
T13 998-1026 other_name denotes lymphoproliferative diseases
T14 1032-1055 other_name denotes dysregulated expression
T15 1059-1068 protein_family_or_group denotes cytokines
T16 1131-1154 cell_line denotes transformed lymphocytes
T17 1188-1214 other_name denotes anti-tumor immune response
T18 1284-1309 other_name denotes impending immune response
T19 1351-1379 other_name denotes lymphoproliferative diseases
T20 1453-1474 other_name denotes lymphoid malignancies
T21 1504-1523 other_name denotes genetic alterations
T22 1535-1547 other_name denotes dysregulated
T23 1548-1556 protein_family_or_group denotes cytokine